In the scientific community, there is growing interest regarding associated symptoms in Takayasu’s arteritis (TA), an autoimmune condition that mainly affects the medium and large arteries. Hearing loss (HL) is a rare complication of TA that is often overlooked and has severe consequences on the quality of life. HL mainly presents as sudden sensorineural hearing loss (SSNHL) and responds to corticosteroid therapy. In the authors’ opinion, the reasons for misdiagnosing HL in patients with TA are lack of evidence re- garding this rare complication and because TA involves large caliber arteries, instead of small vessels that are typical of the inner ear. We recently used HBOT for a 36-year-old woman with TA, who had two SSNHL episodes in different ears in an 11-month period and observed a significant improvement in the patient's hearing. Although this was a single case finding and HBOT was administered together with steroid therapy, the significant recovery of HL in both ears following this therapeutic approach may be worth sharing with the scientific community. In conclusion, we recommend that awareness for inner ear involvement in TA should increase and that HL should be considered a possible complication of TA and should be treated with corticosteroid therapy and, after collecting further evidence, HBOT.

Hearing loss in Takayasu's arteritis: a role for hyperbaric oxygen therapy? / Ralli, Massimo; Greco, Antonio; de Vincentiis, Marco. - In: THE JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY. - ISSN 1308-7649. - 13:3(2017), pp. 417-418. [10.5152/iao.2017.4447]

Hearing loss in Takayasu's arteritis: a role for hyperbaric oxygen therapy?

Ralli, Massimo
Primo
;
Greco, Antonio
Penultimo
;
de Vincentiis, Marco
Ultimo
2017

Abstract

In the scientific community, there is growing interest regarding associated symptoms in Takayasu’s arteritis (TA), an autoimmune condition that mainly affects the medium and large arteries. Hearing loss (HL) is a rare complication of TA that is often overlooked and has severe consequences on the quality of life. HL mainly presents as sudden sensorineural hearing loss (SSNHL) and responds to corticosteroid therapy. In the authors’ opinion, the reasons for misdiagnosing HL in patients with TA are lack of evidence re- garding this rare complication and because TA involves large caliber arteries, instead of small vessels that are typical of the inner ear. We recently used HBOT for a 36-year-old woman with TA, who had two SSNHL episodes in different ears in an 11-month period and observed a significant improvement in the patient's hearing. Although this was a single case finding and HBOT was administered together with steroid therapy, the significant recovery of HL in both ears following this therapeutic approach may be worth sharing with the scientific community. In conclusion, we recommend that awareness for inner ear involvement in TA should increase and that HL should be considered a possible complication of TA and should be treated with corticosteroid therapy and, after collecting further evidence, HBOT.
2017
Takayasu's arteritis; autoimmune disease; hearing loss
01 Pubblicazione su rivista::01f Lettera, Nota
Hearing loss in Takayasu's arteritis: a role for hyperbaric oxygen therapy? / Ralli, Massimo; Greco, Antonio; de Vincentiis, Marco. - In: THE JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY. - ISSN 1308-7649. - 13:3(2017), pp. 417-418. [10.5152/iao.2017.4447]
File allegati a questo prodotto
File Dimensione Formato  
Ralli_Hearing-loss_2017.pdf

accesso aperto

Note: https://advancedotology.org/en/hearing-loss-in-takayasu-s-arteritis-a-role-for-hyperbaric-oxygen-therapy-131126
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.56 MB
Formato Adobe PDF
1.56 MB Adobe PDF
Ralli_Hearing-loss_2017_postprint.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 290.94 kB
Formato Adobe PDF
290.94 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1044599
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact